Which metabolites of Adderall (mixed amphetamine salts) are detectable in urine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amphetamine Metabolites Detectable in Urine Following Adderall Administration

Adderall is excreted primarily as unchanged amphetamine in the urine, with up to 80% appearing as the parent compound rather than metabolites. 1

Primary Urinary Findings

The predominant finding in urine drug testing after Adderall use is unchanged amphetamine (both d- and l-enantiomers), not metabolites. 1 This is because amphetamine undergoes minimal metabolism, with the majority being excreted unchanged through the kidneys. 1

Enantiomer Composition

  • Adderall contains a 3:1 ratio of d-amphetamine to l-amphetamine salts, and this enantiomeric mixture is detectable in urine. 2, 3
  • The d-enantiomer predominates initially after dosing, with the proportion of l-enantiomer increasing over time due to differential metabolism rates. 2, 3
  • Detection of the l-enantiomer is pathognomonic for Adderall use (or other mixed-salt formulations), as pure dextroamphetamine preparations and most illicit amphetamine contain only the d-enantiomer. 2, 3

Detection Parameters

Concentration and Duration

  • Peak amphetamine concentrations in urine range from 2,645 to 5,948 ng/mL after a single 20-mg dose, and from 5,739 to 19,172 ng/mL with repeated daily dosing. 2, 3
  • Amphetamine remains detectable above the 500 ng/mL confirmatory cutoff for up to 47.5 hours after a single dose and up to 60 hours after the last dose of a multi-day regimen. 2, 3
  • The drug can be detected at trace levels (≥5 ng/mL) for even longer periods. 2, 3

Important Testing Considerations

  • Not all samples containing ≥500 ng/mL total amphetamine test positive on immunoassay screening due to differing cross-reactivity of the d- and l-enantiomers with antibodies used in screening tests. 2, 3
  • Drug concentration profiles are highly variable both within and between individuals due to urine dilution and pH fluctuations. 2
  • Methylphenidate is NOT detected on routine amphetamine panels, so a positive amphetamine result cannot be explained by methylphenidate use. 1, 4

Metabolic Pathways (Minor Components)

While the guideline evidence emphasizes that amphetamine is predominantly excreted unchanged, the metabolic pathways mentioned include: 1

  • p-Hydroxylation
  • N-Demethylation
  • Deamination
  • Conjugation

However, these pathways account for only a small fraction of elimination compared to renal excretion of unchanged drug. 1

Clinical Pitfalls

  • Standard immunoassay screening tests are presumptive only and require gas chromatography-mass spectrometry (GC-MS) confirmation, particularly when results will impact clinical decisions. 1, 4
  • Enantiomer-specific analysis using GC-MS can definitively distinguish Adderall use from other amphetamine sources by detecting the characteristic l-enantiomer. 2, 3
  • Pseudoephedrine in over-the-counter cold medications can cause false-positive amphetamine results on screening tests. 1, 4
  • The presence of amphetamine in urine cannot distinguish between appropriate therapeutic use and misuse of prescribed Adderall. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Interpreting Urine Drug Test Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.